Overall, LRRK2 variant carriers, particularly those with p.R1628P, appeared to have a more “benign” disease course, with a lower prevalence of significant non-motor features (dementia and orthostatic hypotension) that are known to have a substantial impact on quality of life and survival in PD patients52–54. This evidence concerns the gene LRRK2 and hypotensive disorder.